Emmaus Life Sciences, Inc. is a commercial-stage biopharmaceutical company focused on rare and orphan diseases. Its sole product, Endari (prescription grade L-glutamine oral powder), is FDA-approved to reduce acute complications of sickle cell disease in adults and pediatric patients aged five and older. Endari is also approved in UAE, Qatar, Kuwait, Bahrain, and Oman, and sold through distributors in the U.S. and MENA region.
expected 2026-11-13
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-31 | 2025-12-31 | 0001193125-26-132925 | EDGAR | 59K words |
| 2025-04-14 | 2024-12-31 | 0000950170-25-053744 | EDGAR | 62K words |
| 2024-07-03 | 2023-12-31 | 0000950170-24-080918 | EDGAR | 66K words |
| 2023-03-31 | 2022-12-31 | 0000950170-23-011328 | EDGAR | 70K words |
| 2022-03-31 | 2021-12-31 | 0001564590-22-013054 | EDGAR | — |
| 2021-05-04 | 2020-12-31 | 0001564590-21-022930 | EDGAR | — |
| 2021-01-25 | 2019-12-31 | 0001564590-21-001977 | EDGAR | — |
| 2018-12-11 | 2018-09-30 | 0001615774-18-014245 | EDGAR | — |
| 2017-12-29 | 2017-09-30 | 0001615774-17-007691 | EDGAR | — |
| 2016-12-22 | 2016-09-30 | 0001615774-16-009049 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-14 | 2026-06-30 | 0001193125-26-351833 | EDGAR | 25K words |
| 2025-11-14 | 2025-09-30 | 0001193125-25-282675 | EDGAR | 23K words |
| 2025-08-14 | 2025-06-30 | 0000950170-25-108770 | EDGAR | 22K words |
| 2025-05-15 | 2025-03-31 | 0000950170-25-072520 | EDGAR | 21K words |
| 2024-11-19 | 2024-09-30 | 0000950170-24-128621 | EDGAR | 26K words |
| 2024-09-10 | 2024-06-30 | 0000950170-24-105016 | EDGAR | 25K words |
| 2024-09-10 | 2024-03-31 | 0000950170-24-105004 | EDGAR | 23K words |
| 2023-11-14 | 2023-09-30 | 0000950170-23-063225 | EDGAR | 26K words |
| 2023-08-14 | 2023-06-30 | 0000950170-23-042300 | EDGAR | 13K words |
| 2023-05-15 | 2023-03-31 | 0000950170-23-021891 | EDGAR | 23K words |
| 2022-11-14 | 2022-09-30 | 0001564590-22-037658 | EDGAR | 24K words |
| 2022-08-15 | 2022-06-30 | 0001564590-22-029481 | EDGAR | 23K words |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-14 | 0001213900-26-089912 | EDGAR | 2K words |
| 2026-03-31 | 0001213900-26-036886 | EDGAR | 2K words |
| 2026-03-04 | 0001213900-26-023644 | EDGAR | 1K words |
| 2025-12-31 | 0001213900-25-126728 | EDGAR | 1K words |
| 2025-12-22 | 0001213900-25-124513 | EDGAR | 15K words |
| 2025-12-19 | 0001213900-25-123836 | EDGAR | 0K words |
| 2025-11-14 | 0001213900-25-110878 | EDGAR | 2K words |
| 2025-08-14 | 0001213900-25-076672 | EDGAR | 2K words |
| 2025-07-01 | 0001213900-25-060349 | EDGAR | 1K words |
| 2025-05-15 | 0001213900-25-044286 | EDGAR | 2K words |
355 total filings indexed. 323 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0000822370 |
| Ticker | EMMA |
| Exchange | OTC |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/EMMA (~200 tokens, structured JSON with cryptographic provenance)